| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |